‘Negligible’ melanoma risk observed in patients treated with methotrexate
Source: Healio, October 2022
Findings from a comprehensive systematic review and meta-analysis showed a “negligible” risk for melanoma among individuals treated with methotrexate.
Mabel K. Yan, MBBS, of the Victorian Melanoma Service at The Alfred Hospital, Anita E. Wluka, MBBS, PhD, of the School of Public Health and Preventive Medicine at Monash University, and colleagues noted that findings from previous studies have demonstrated a possible association between methotrexate and melanoma.
“Because previous studies have suggested an association, patients ask about this risk,” Yan told Healio. “Melanoma awareness is perhaps higher in Australia than elsewhere, as melanoma is relatively more common here.”